Hypermarcas (OTCMKTS:HYPMY) Short Interest Down 94.7% in May

Hypermarcas (OTCMKTS:HYPMY) saw a large decrease in short interest in May. As of May 15th, there was short interest totaling 3,352 shares, a decrease of 94.7% from the April 30th total of 63,443 shares. Approximately 0.0% of the company’s stock are short sold. Based on an average daily volume of 57,615 shares, the days-to-cover ratio is currently 0.1 days.

Hypermarcas Stock Up 0.5%

OTCMKTS:HYPMY traded up $0.02 on Wednesday, hitting $4.41. The stock had a trading volume of 23,637 shares, compared to its average volume of 35,697. The company has a debt-to-equity ratio of 0.61, a quick ratio of 0.84 and a current ratio of 1.27. The stock has a market cap of $3.10 billion, a P/E ratio of 9.19 and a beta of 0.73. Hypermarcas has a 1 year low of $3.71 and a 1 year high of $5.50. The firm’s fifty day simple moving average is $4.53 and its two-hundred day simple moving average is $4.51.

Hypermarcas (OTCMKTS:HYPMY) last posted its quarterly earnings data on Wednesday, April 29th. The company reported $0.10 EPS for the quarter. The firm had revenue of $383.13 million during the quarter. Hypermarcas had a net margin of 19.41% and a return on equity of 14.08%. Analysts predict that Hypermarcas will post 0.53 earnings per share for the current year.

Wall Street Analysts Forecast Growth

Separately, Zacks Research raised shares of Hypermarcas to a “hold” rating in a research report on Wednesday, April 29th. One equities research analyst has rated the stock with a Strong Buy rating and one has assigned a Hold rating to the company. Based on data from MarketBeat.com, Hypermarcas has an average rating of “Buy”.

About Hypermarcas

Hypermarcas SA is a Brazil-based consumer health and pharmaceutical company whose shares trade over the counter in the United States under the symbol HYPMY. Founded in the early 2000s and headquartered in Rio de Janeiro, the company operates as a holding group for a broad portfolio of branded products in the healthcare and personal care sectors.

Through its various subsidiaries, Hypermarcas develops, manufactures and markets prescription and over-the-counter medications, alongside personal care, baby care, home care and nutritional supplement products.